Teva Pharmaceutical Industries TEVA
NYSE TEVA
$37.16 -0.31 (-0.83%)
At close: Aug 20, 2026 · 10:51 AM UTC

Teva Pharmaceutical Industries (TEVA) Change in Inventory (2025 - 2026)

Teva Pharmaceutical Industries' (TEVA) quarterly Change in Inventory came in at -$59.0 million in Q2 2026, up 3.28% YoY from -$57.1 million in Q2 2025, and up 36.56% on a QoQ basis from -$93.0 million in Q1 2026.

Teva Pharmaceutical Industries (TEVA) Change in Inventory (2025 - 2026) Analysis & Trends

Teva Pharmaceutical Industries (TEVA) has 2 years of Change in Inventory data on file, last reported at -$59.0 million in Q2 2026.

  • Quarterly Change in Inventory rose 3.28% year-over-year to -$59.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$333.0 million (changed N/A YoY) and the FY2025 annual result came in at $152.0 million, down 8.43% from the prior year.
  • Change in Inventory advanced to -$59.0 million in Q2 2026, from -$93.0 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of -$59.0 million in Q2 2026 to a low of -$120.0 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Haleon 43.65 Bn 42.68 Bn - -
2 Teva Pharmaceutical Industries 43.09 Bn 39.44 Bn 2.15 Bn -59.00 Mn
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn 23.00 Mn
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn -209.58 Mn
5 United Therapeutics 22.11 Bn 19.45 Bn 683.80 Mn 17.70 Mn
6 Viatris 18.77 Bn 17.88 Bn 1.46 Bn 99.50 Mn
7 Neurocrine Biosciences 15.62 Bn 15.23 Bn 935.80 Mn 6.50 Mn
8 Elanco Animal Health 12.07 Bn 11.54 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.09 Bn 9.93 Bn - -
10 Alkermes 8.20 Bn 7.54 Bn 397.90 Mn -7.44 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -59.00 Mn
Jun 30, 2026 -59.00 Mn
Mar 31, 2026 -93.00 Mn
Mar 31, 2026 -93.00 Mn
Jun 30, 2025 -61.00 Mn
Jun 30, 2025 -61.00 Mn
Mar 31, 2025 -120.00 Mn
Mar 31, 2025 -120.00 Mn